Federal contractor profile
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
UEI JMW6R9VB27L9CAGE 5831NCompany website ↗
Active
Overview
- Legal name
- RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
- Registered location
- GRAZ, AUT
- Website
- Company website ↗
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Latest award activity
- Sep 4, 2026
Read company summary
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH is associated with UEI JMW6R9VB27L9 and CAGE 5831N in public federal records. AcornBids currently links 1 prime award totaling $733.5K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). Its public SAM.gov registration lists GRAZ, AUT.
At a glance
Lifetime prime obligations$733.5K
Prime awards1
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
- UEI
- JMW6R9VB27L9
- CAGE
- 5831N
- Registered address
- INFFELDGASSE 13, GRAZ, 8010, AUT
- Registration status
- Active
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM activation
- Feb 4, 2026
- Initial registration
- May 5, 2014
- Entity start
- Jun 9, 2008
- SAM updated
- Feb 4, 2026
- Registration expires
- Feb 4, 2027
- Fiscal year end
- Jun 30
- Place of incorporation
- AUT
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75F40126C00098NEXT GENERATION PROCESS DEVELOPMENT AND QUALITY CONTROL IN PROTEIN LYOPHILIZATION USING MECHANISTIC AND AI APPROACHES | Department of Health and Human Services | $733.5K | Sep 11, 2026 | Sep 10, 2028 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 4, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 5, 2014 |
| Entity start | Jun 9, 2008 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| THOMAS KLEIN | Government business | Contact method not published | SAM registration | Not available |
| JOHANNES KHINAST | Alternate government business | Contact method not published | SAM registration | Not available |
| CHRISTIAN VOGL | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
70 awards
53 awards
36 awards
34 awards
30 awards
About RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
INFFELDGASSE 13, GRAZ 8010, AUT
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit